|
|
New No.3, Appaiar Lane, Second Floor,
Royapuram, Chennai - 600 013, Tamilnadu, India
Email - , Phone - +9144 25984175, Mobile - +91 94441 62346
|
|
|
FAQ
> Glossary of Terms > I Series > Impurity
Profile
|
| |
Pharmaceutical & Cleanroom Glossary of Terms
A Series , B
Series , C Series , D
Series , E Series , F
Series , G Series , H
Series , I Series , K Series
, L Series , M
Series , N Series , O
Series , P Series , Q
Series , R Series , S
Series , T Series , U
Series , V Series , W
Series , X
Series , Y Series , Z
Series
IBC(Intermediate
Bulk Container), IDLH(Immediately
Dangerous to Life and Health), Immune
Response, Immuno
Electrophoresis, Immunity,
Immunogen, Immunoglobulin-Ig,
Immunoglobulin
A - IgA, Immunoglobulin(IgA,
IgD, IgE, IgG, IgM), Immunology,
Immunoproteins,
Imprinting, Impurity,
Impurity Profile, Inactive
Ingredient, Inactivation,
Incidential Release,
Inclusion Body,
Inclusions, IND(Investigational
New Drug) Application, Indirect
Impact System, Inert,
Infarct, Infected,
Infectious, Infectious
Agent, Infiltration,
Informatics, Infusion,
Injection, In-line,
In-process Control,
Innocuous, Inoculum
Learn About Deadly
Cancer Mesothelioma due to Asbestos Exposure, it can affect
any one in the world
Impurity Profile
A description of the identified and unidentified impurities present
in a typical batch of API (Active Pharmaceutical Ingredient) produced
by a specific controlled production process. It includes the identity
or some qualitative analytical designation (e.g. retention time),
the range of each impurity observed, and type of each identified
impurity. For each API there should be an impurity profile describing
the identified and unidentified impurities present in a typical
batch. The impurity profile is normally dependent upon the process
or origin of the API.
|
|
| |
|
|
|